Matches in Nanopublications for { ?s ?p "[The anti-CD20 monoclonal antibody rituximab has been less successful in treating chronic lymphocytic leukemia (CLL) than lymphoma, possibly due to the lower density of CD20 on B lymphocytes from CLL patients than on those from lymphoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP468091.RAgRQVZ4TP118J6TCE945pK77qviUCsr6wEVlhjAO7LKM130_assertion description "[The anti-CD20 monoclonal antibody rituximab has been less successful in treating chronic lymphocytic leukemia (CLL) than lymphoma, possibly due to the lower density of CD20 on B lymphocytes from CLL patients than on those from lymphoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP468091.RAgRQVZ4TP118J6TCE945pK77qviUCsr6wEVlhjAO7LKM130_provenance.
- assertion description "[The anti-CD20 monoclonal antibody rituximab has been less successful in treating chronic lymphocytic leukemia (CLL) than lymphoma, possibly due to the lower density of CD20 on B lymphocytes from CLL patients than on those from lymphoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The anti-CD20 monoclonal antibody rituximab has been less successful in treating chronic lymphocytic leukemia (CLL) than lymphoma, possibly due to the lower density of CD20 on B lymphocytes from CLL patients than on those from lymphoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP693221.RAmAXrnhtEhTymmvO3eoUZWC1dPe9jeUofgXOzusWF18Y130_assertion description "[The anti-CD20 monoclonal antibody rituximab has been less successful in treating chronic lymphocytic leukemia (CLL) than lymphoma, possibly due to the lower density of CD20 on B lymphocytes from CLL patients than on those from lymphoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP693221.RAmAXrnhtEhTymmvO3eoUZWC1dPe9jeUofgXOzusWF18Y130_provenance.
- NP693219.RALJ3gY1KSJpU82mlNEdlBGxg7JkPTnwaKh0sTHzSjRKw130_assertion description "[The anti-CD20 monoclonal antibody rituximab has been less successful in treating chronic lymphocytic leukemia (CLL) than lymphoma, possibly due to the lower density of CD20 on B lymphocytes from CLL patients than on those from lymphoma patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP693219.RALJ3gY1KSJpU82mlNEdlBGxg7JkPTnwaKh0sTHzSjRKw130_provenance.